$IDXG Latest Insider Purchases and Institutional Ownerships:
2016-02-03 Glorikian Harry Director Acquired 127,696
2016-02-03 KEEGAN JOSEPH D Director Acquired 127,696
2016-02-03 STOVER JACK E Interim President and CEO Director Acquired 294,756
2016-02-03 SULLIVAN STEPHEN J Director Acquired 295,656
2017-06-23 SC 13G ARMISTICE CAPITAL, LLC Acquired 965,784
John P. Dugan (Founder): 4,869,878 common shares
Other Insiders Approximately: 2,672,149 shares collectively
Total Insiders: 7,542,027 shares
Institutional Ownership: 30.6% 5.5 mil shares (Increased to 6.5 mil as of June 23rd)
Largest Institutional Holder: Heartland Advisors: 2,994,313
Recent News Headlines:
2017-06-28 Interpace Diagnostics Announces National Contract With Aetna
2017-06-26 Interpace Diagnostics Announces Coverage Of Thyroid Test By Premera Blue Cross
2017-06-16 Interpace Diagnostics Announces Pricing Of $13.7 Million Underwritten Public Offering Of Common Stock And Common Warrants
2017-06-06 Interpace Diagnostics Announces Agreement With Einstein Medical Center Of Philadelphia
2017-05-25 Interpace Diagnostics Announces Launch Of Enhancement To Thyroid Testing Services
2017-05-16 Interpace Diagnostics Group's (IDXG) CEO Jack Stover on Q1 2017 Results - Earnings Call Transcript
2017-05-15 Interpace Diagnostics To Host Conference Call And Webcast To Discuss First Quarter 2017 Financial Results On Monday May 15, 2017
2017-05-10 Interpace Diagnostics Presents New Data on PancraGEN® at DDW
2017-04-20 Interpace Diagnostics Eliminates Long Term Secured Debt
2017-04-18 Interpace Diagnostics Announces Coverage Of ThyraMIR With UnitedHealthcare
2017-04-13 Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement
2017-04-04 A Look at Interpace Diagnostics Financials, Drug Pipeline and Market Opportunity
2017-04-03 Interpace Diagnostics Announces European Patent Approval For Underlying Technology Of Its Thyramir Microrna Classifier
News 
Market Data 
Discover 
